CRISPR Therapeutics

In News

Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP) - Seeking Alpha

Seeking Alpha - Dec 04, 2025

RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform - Yahoo Finance

Yahoo Finance - Nov 18, 2025

State Board of Administration of Florida Retirement System Acquires New Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat

MarketBeat - Dec 07, 2025

2 Stocks That Could Soar by 52% and 282%, According to Wall Street - The Motley Fool

The Motley Fool - Dec 07, 2025

CRISPR Therapeutics Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily

Investor's Business Daily - Dec 04, 2025

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides - Cleveland Clinic Newsroom

Cleveland Clinic Newsroom - Nov 08, 2025

Crispr Therapeutics AG: Stock Surge Amid Challenges - TipRanks

TipRanks - Dec 06, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Nasdaq Index Biotech Momentum - Kalkine Media

Kalkine Media - Dec 04, 2025

Is CRISPR Therapeutics AG stock a bargain at current levels - July 2025 Catalysts & Safe Capital Investment Plans - Newser

Newser - Dec 04, 2025

Crispr Therapeutics pares loss amid takeover speculation (CRSP:NASDAQ) - Seeking Alpha

Seeking Alpha - Dec 01, 2025

Positive CTX310 Phase 1 Results Might Change The Case For Investing In CRISPR Therapeutics (CRSP) - Yahoo Finance

Yahoo Finance - Nov 16, 2025

CRISPR Therapeutics AG $CRSP Shares Bought by Legal & General Group Plc - MarketBeat

MarketBeat - Dec 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment